Share Price:

APNASPENAspen Pharmacare Hldgs16907-5 (-0.03%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

New Business Development

Team Overview

Our business development team is at the heart of the company’s growth agenda and focuses on capturing new business opportunities and closing portfolio gaps with customers, manufacturing partnerships and suppliers.
 
Part of our team’s key functions includes acquiring new customers, identifying new market opportunities and overseeing growth projects, preparing sales forecasts and forecasting revenues based on projected revenues. This allows us to develop strategies to support our business objectives and also to maintain our leadership position in the pharmaceutical industry.

Working At Aspen

We believe that doing business in a sustainable and responsible manner is integral to our purpose, our values and our philosophy “Healthcare. We Care”.


Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.

 

Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.

Innovation

We constantly search for better ways of doing things

Excellence

We strive to be the best we can be to deliver the highest standards

Commitment

We go the extra mile, seeking to exceed expectations

Teamwork

We optimise our performance by pulling together

Integrity

Our integrity is not negotiable

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.